Health Populis Hot Points: The combined public health crisis of diabetes and obesity is associated with three converging driving forces: A diabesity epidemic, the actual convergence of the two conditions which is expected to impact nearly one-half of the U.S
CB1 and CB2 share 44% amino acid homology and are G protein-coupled receptors (GPCRs)
The GP may need to review the overall diabetes management plan, assess for potential drug interactions, or investigate alternative causes of thirst such as hypercalcaemia or diabetes insipidus
Other GLP-1 medications like Ozempic (approved for diabetes, not weight loss) and Mounjaro aren't included in the Bridge Program for weight loss purposes
Consumption during pregnancy and breastfeeding after consulting a doctor
Sitagliptin in Combination with Metformin and Insulin In a 24-week placebo-controlled study of sitagliptin 100 mg as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin and insulin (sitagliptin, N=229
